|
Volumn 9, Issue 1 Suppl, 2003, Pages 20-23
|
Strategies for optimizing treatment outcomes.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HYPOCHOLESTEROLEMIC AGENT;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
BLOOD;
CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
DIET THERAPY;
DRUG ANTAGONISM;
ECONOMICS;
HUMAN;
HYPERCHOLESTEROLEMIA;
METABOLISM;
MORTALITY;
PRACTICE GUIDELINE;
REVIEW;
RISK ASSESSMENT;
ANTICHOLESTEREMIC AGENTS;
CHOLESTEROL, LDL;
CLINICAL TRIALS;
CORONARY DISEASE;
DIET THERAPY;
HUMANS;
HYPERCHOLESTEROLEMIA;
PRACTICE GUIDELINES;
RISK ASSESSMENT;
|
EID: 0642308518
PISSN: 10834087
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (3)
|
References (14)
|